DOI: 10.1001/jamadermatol.2026.3051 ISSN: 2168-6068

BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus

Moritz Ronicke, Tobias Rothe, Fabian Müller, Carola Berking, Georg Schett, Ricardo Grieshaber-Bouyer, Michael Sticherling

This case report describes 2 patients with pemphigus and off-label teclistamab use.